南亚裔头颈癌患者诊断分期与生存结局
该回顾性队列研究基于SEER Research Plus 17数据库,纳入2006至2020年确诊的鳞状头颈癌患者92,664例(南亚裔1066例、其他亚裔3260例、非西班牙裔白人88,338例),比较诊断分期与生存结局。结果显示南亚裔患者诊断时晚期风险更高(OR 1.48,95%CI 1.29-1.70),疾病特异性生存更差(HR 1.30,95%CI 1.16-1.46),提示评估头颈癌结局差异时应拆分亚裔族群。
要点
- 南亚裔头颈鳞癌患者诊断时晚期风险高于其他亚裔和非西班牙裔白人(OR 1.48)。
- 南亚裔患者疾病特异性生存较其他亚裔和非西班牙裔白人更差(HR 1.30)。
- 评估头颈癌结局差异时应拆分亚裔族群,避免合并掩盖差异。
核心结论
- 南亚裔头颈癌患者更易以晚期分期就诊且生存更差,评估结局差异时应拆分亚裔族群。
研究设计与样本
- 回顾性 population-based 队列研究,数据来自SEER Research Plus 17数据库。
- 纳入2006至2020年确诊的鳞状头颈癌患者共92,664例:南亚裔1066例、其他亚裔3260例、非西班牙裔白人88,338例。
- 采用逻辑回归评估种族/民族与晚期(III/IV期 vs I/II期)的关联,Kaplan-Meier分析和Cox比例风险回归评估总生存与疾病特异性生存。
主要发现
- 调整后逻辑回归显示南亚裔诊断时晚期风险高于其他亚裔(OR 1.13,95%CI 1.05-1.22)和非西班牙裔白人(OR 1.48,95%CI 1.29-1.70)。
- 调整后Cox回归显示其他亚裔总生存改善(HR 0.89,95%CI 0.84-0.94),南亚裔总生存与非西班牙裔白人相似(HR 1.09,95%CI 0.99-1.21)。
- 南亚裔疾病特异性生存较其他亚裔(HR 1.05,95%CI 0.98-1.12)和非西班牙裔白人更差(HR 1.30,95%CI 1.16-1.46)。
临床怎么用
- 临床上对南亚裔头颈癌患者应加强早期筛查和分期评估意识,关注晚期就诊风险。
- 在头颈癌预后咨询和随访中,可考虑南亚裔患者疾病特异性生存较差的可能。
- 人群健康统计和差异研究中应拆分亚裔亚组,避免合并分析掩盖差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare head and neck cancer (HNC) stage at diagnosis and survival outcomes between South Asian, Other Asian, and non-Hispanic white individuals in the United States. STUDY DESIGN: Retrospective population-based cohort study. SETTING: Data from Surveillance, Epidemiology, and End Results Research Plus 17 database. METHODS: Patients diagnosed with squamous HNC from 2006 to 2020 were categorized as South Asian, Other Asian, and non-Hispanic white. Logistic regression assessed the association between race/ethnicity and advanced-stage disease (stage III/IV vs I/II). Overall survival (OS) and disease-specific survival (DSS) outcomes were evaluated using Kaplan-Meier analysis and Cox proportional hazards regression models, respectively. RESULTS: Among 92,664 patients (1066 South Asian, 3260 Other Asian, and 88,338 non-Hispanic white individuals), adjusted logistic regression showed South Asian individuals had a higher risk of advanced stage at diagnosis (odds ratio [OR] 1.48, 95% CI 1.29-1.70) than Other Asian (OR 1.13, 95% CI 1.05-1.22) and non-Hispanic white individuals. Adjusted Cox regression showed Other Asian (hazard ratio [HR] 0.89, 95% CI 0.84-0.94) individuals had improved OS, while South Asian individuals had similar OS (HR 1.09, 95% CI 0.99-1.21) as non-Hispanic white individuals. South Asian individuals had worse DSS (HR 1.30, 95% CI 1.16-1.46) than Other Asian (HR 1.05, 95% CI 0.98-1.12), and non-Hispanic white individuals. CONCLUSION: South Asian individuals with HNC are more likely to present with advanced disease stage and have worse survival compared with Other Asian and non-Hispanic white individuals, highlighting the importance of disaggregating Asian ethnic groups when assessing HNC outcome disparities.
引用
- Huynh JD, Halagur AS, Polkampally S, et al. Head and Neck Cancer Stage at Diagnosis and Survival Outcomes Among South Asian Patients. Otolaryngol Head Neck Surg. 2026. PMID: 41865270. doi:10.1002/ohn.70215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。